5. CONCLUSION:
The small compound eritadenine has exhibited excellent properties
against all aforementioned categories of target, toxicity and ADME so it
could be propagated as a drug to combat the SARS-CoV-2. Whereas the
other compounds also possessed such immunomodulatory properties as
mentioned in the existing literature mentioned above. However, this work
is foundational, but the results are promising and further studies of
these ligands in vitro and in vivo should be studied to
decipher the therapeutic role of these compounds.